Back to Journals » Journal of Pain Research » Volume 10

Original Research

A randomized, Phase IIb study investigating oliceridine (TRV130), a novel µ-receptor G-protein pathway selective (µ-GPS) modulator, for the management of moderate to severe acute pain following abdominoplasty

       
Total article views   HTML views PDF downloads Totals
15,665 Dovepress* 12,977+ 2,324 15,301
PubMed Central* 2,688 950 3,638
Totals 15,665 3,274 18,939
*Since 6 October 2017
Total mentioned Facebook Delicious Reddit Twitter Others
9 0 0 0 2 7

View citations on PubMed Central and Google Scholar